Back to results
US 11,110,107 B2Granted
Methods for treatment of cancer by targeting SIRT5
AssigneeCornell University
InventorHening Lin
Life of this patent
Estimating the term…
Abstract
This disclosure demonstrates that inhibition of Sirt5 can suppress malignant transformation of cells. Therefore, methods of treating cancer based on inhibition of Sirt5 are disclosed.
Claims5
A compound that inhibits Sirt5 demalonylase or desuccinylase activity, having the formula:
- wherein:
- R1 is a carboxylate alkyl ester;
- R2 is S;
- X0, X1, X2, X3, X6, and X7 are each —CH2—;
- X4 is —NR5—, wherein R5 is H, methyl, ethyl, isopropyl, phenyl, or benzyl;
- X5 is —CH2— or —NR5—;
- R3 and R4 are independently selected from H, hydrocarbon (R), amino acid, dipeptide, tripeptide, oligopeptide, protein, nucleobase, nucleotide, dinucleotide, trinucleotide, oligonucleotide, monosaccharide, disaccharide, oligosaccharide, and protecting groups or a combination thereof or modified form thereof.
4 more elements
Dependencies are inferred from the claim text.